Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001251779-26-000002
Filing Date
2026-02-27
Accepted
2026-02-27 16:05:36
Documents
1
Period of Report
2026-02-26

Document Format Files

Seq Description Document Type Size
1 form4-02272026_040231.html 4  
1 form4-02272026_040231.xml 4 6813
  Complete submission text file 0001251779-26-000002.txt   8454
Mailing Address ALTIMMUNE, INC. 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878
Business Address
WEAVER GREGORY L (Reporting) CIK: 0001251779 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 26699621

Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)